Acquiring Company
Aethlon Medical
Acquired Company
North Immunology
San DiegoAustinBiotechnologyHealth CareMedicalTherapeuticsBiotechnologyHealth CareTherapeuticsDescription
Aethlon Medical has announced a definitive merger agreement with North Immunology in an all-stock transaction. The merger aims to advance the development of NOR-101, a bispecific antibody for atopic dermatitis. The combined entity will operate as North Immunology, Inc. and is set to trade on the Nasdaq Capital Market under a new ticker symbol. This merger also includes a $180 million private placement to fund their operations.
Quick answer
Aethlon Medical is acquiring North Immunology, announced September 17, 2026. Aethlon Medical is based in San Diego, California, United States.
- How much did Aethlon Medical pay for North Immunology?
- The deal value was not disclosed.
- What does Aethlon Medical do?
- Aethlon Medical is a medical therapeutic company focused on developing the Hemopurifier, a clinical stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in..
- Where are Aethlon Medical and North Immunology based?
- Aethlon Medical is based in San Diego, California, United States. North Immunology is based in Austin, Texas, United States.
- Who are the decision-makers at Aethlon Medical?
- Fundz holds 1 contact at Aethlon Medical. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- BioMarin to acquire Alesta Therapeutics for $275 million, $275M (August 18, 2026)
- Vivos Therapeutics Acquires SOD Sciences in Strategic Asset Exchange (October 15, 2026)
- Bedfont® acquires coVita™ to enhance US presence (October 13, 2026)
- Medtronic to exchange shares for MiniMed Group stock (October 7, 2026)
- SRX Global to acquire CERo Therapeutics (October 7, 2026)
- Lifecore Biomedical Announces Merger with Lifecore Inc. (September 27, 2026)
Who to call at Aethlon Medical, and when
When Aethlon Medical changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Aethlon Medical raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aethlon Medical, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aethlon Medical. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aethlon Medical makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired North Immunology?
North Immunology was acquired by Aethlon Medical, based in San Diego. The deal was reported on September 17, 2026. Aethlon Medical is publicly traded (AEMD) and operates in Biotechnology.
When did Aethlon Medical acquire North Immunology?
Aethlon Medical's acquisition of North Immunology was reported on September 17, 2026. Aethlon Medical has announced a definitive merger agreement with North Immunology in an all-stock transaction. The merger aims to advance the development of NOR-101, a bispecific antibody for atopic dermatitis. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does North Immunology do?
North Immunology is a privately held biotechnology company developing bispecific antibodies aimed at treating immune and inflammatory diseases. It is privately held, operating in Biotechnology, and is based in Austin.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.